1. Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes. (April 2014) Authors: Baker, D J; Atkinson, A M; Wilkinson, G P; Coope, G J; Charles, A D; Leighton, B Journal: British journal of pharmacology Issue: Volume 171:Number 7(2014:Apr.) Page Start: 1629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes. (April 2014) Authors: Baker, D J; Wilkinson, G P; Atkinson, A M; Jones, H B; Coghlan, M; Charles, A D; Leighton, B Journal: British journal of pharmacology Issue: Volume 171:Number 7(2014:Apr.) Page Start: 1642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗